D-Index & Metrics Best Publications
Biology and Biochemistry
Sweden
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 72 Citations 14,860 210 World Ranking 4030 National Ranking 57

Research.com Recognitions

Awards & Achievements

2023 - Research.com Biology and Biochemistry in Sweden Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Biochemistry
  • Internal medicine

Lipoprotein lipase, Biochemistry, Lipase, Internal medicine and Endocrinology are his primary areas of study. His Lipoprotein lipase research is multidisciplinary, incorporating perspectives in Triglyceride, Heparin and Lipoprotein. His study looks at the relationship between Biochemistry and fields such as Human plasma, as well as how they intersect with chemical problems.

His Lipase research incorporates elements of Hydrolysis, Digestion and Chromatography. His Enzyme study combines topics in areas such as Bovine milk and Plasma lipoprotein. His research integrates issues of GPIHBP1 and Methionine in his study of Adipose tissue.

His most cited work include:

  • Postprandial lipoproteins and progression of coronary atherosclerosis (464 citations)
  • Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue (313 citations)
  • Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources. (290 citations)

What are the main themes of his work throughout his whole career to date?

Thomas Olivecrona spends much of his time researching Lipoprotein lipase, Biochemistry, Internal medicine, Endocrinology and Lipase. His Lipoprotein lipase research includes elements of Very low-density lipoprotein, Lipoprotein and Heparin. His work on Lipolysis, Metabolism and Amino acid as part of general Biochemistry research is frequently linked to Mutant, thereby connecting diverse disciplines of science.

His research ties Methionine and Endocrinology together. His research in Lipase intersects with topics in Cycloheximide, Hydrolysis, Salt, Digestion and DNA sequencing. The Triglyceride study combines topics in areas such as Low-density lipoprotein and Fatty acid.

He most often published in these fields:

  • Lipoprotein lipase (70.13%)
  • Biochemistry (60.61%)
  • Internal medicine (46.75%)

What were the highlights of his more recent work (between 1998-2017)?

  • Lipoprotein lipase (70.13%)
  • Internal medicine (46.75%)
  • Endocrinology (46.32%)

In recent papers he was focusing on the following fields of study:

Thomas Olivecrona mainly investigates Lipoprotein lipase, Internal medicine, Endocrinology, Biochemistry and Lipase. His Lipoprotein lipase study combines topics from a wide range of disciplines, such as Chylomicron, Endothelium, Lipoprotein and Lipolysis. His work on Heparin, Triglyceride and Hepatic lipase as part of his general Internal medicine study is frequently connected to Downregulation and upregulation, thereby bridging the divide between different branches of science.

Thomas Olivecrona focuses mostly in the field of Endocrinology, narrowing it down to topics relating to Fat emulsion and, in certain cases, Body mass index. His study on Lipoprotein lipase activity and Nucleic acid sequence is often connected to Mutant and Transgene as part of broader study in Biochemistry. In general Lipase, his work in Pancreatic lipase is often linked to Human breast linking many areas of study.

Between 1998 and 2017, his most popular works were:

  • Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue (313 citations)
  • Triglyceride lipases and atherosclerosis. (195 citations)
  • Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia. (101 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Biochemistry
  • Internal medicine

Thomas Olivecrona mostly deals with Lipoprotein lipase, Internal medicine, Endocrinology, Adipose tissue and Lipase. Lipoprotein lipase is a subfield of Biochemistry that Thomas Olivecrona tackles. His Heparin, Anticoagulant, Metabolism and HYPERLIPOPROTEINEMIA TYPE I study in the realm of Internal medicine interacts with subjects such as Mink.

In the field of Endocrinology, his study on Chylomicron and Animal model overlaps with subjects such as Mutation. His studies in Adipose tissue integrate themes in fields like Endothelium and Insulin, Insulin resistance. In his research on the topic of Lipase, Triacylglycerol lipase and Endothelial lipase is strongly related with Plasma protein binding.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Postprandial lipoproteins and progression of coronary atherosclerosis

Fredrik Karpe;George Steiner;George Steiner;Kristine Uffelman;Thomas Olivecrona.
Atherosclerosis (1994)

626 Citations

Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources.

Richard J. Havel;Christopher J. Fielding;Thomas Olivecrona;Virgie G. Shore.
Biochemistry (1973)

439 Citations

Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue

Valentina Sukonina;Aivar Lookene;Thomas Olivecrona;Gunilla Olivecrona.
Proceedings of the National Academy of Sciences of the United States of America (2006)

403 Citations

Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix.

Shlomo Eisenberg;Ephraim Sehayek;Thomas Olivecrona;Israel Vlodavsky.
Journal of Clinical Investigation (1992)

364 Citations

Metabolism of triglyceride-rich lipoproteins during alimentary lipemia.

F Karpe;G Steiner;T Olivecrona;L A Carlson.
Journal of Clinical Investigation (1993)

343 Citations

Postprandial lipemia, fenofibrate and coronary artery disease

H.S. Simpson;C.M. Williamson;T. Olivecrona;S. Pringle.
Atherosclerosis (1990)

338 Citations

Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo.

H Semb;J Peterson;J Tavernier;T Olivecrona.
Journal of Biological Chemistry (1987)

320 Citations

Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport.

Jonas Peterson;Bernard E. Bihain;Gunilla Bengtsson-Olivecrona;Richard J. Deckelbaum.
Proceedings of the National Academy of Sciences of the United States of America (1990)

266 Citations

Triglyceride lipases and atherosclerosis.

Gunilla Olivecrona;Thomas Olivecrona.
Current Opinion in Lipidology (2010)

254 Citations

The purification of a lipoprotein lipase from bovine skim milk.

Torbjörn Egelrud;Thomas Olivecrona.
Journal of Biological Chemistry (1972)

227 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Thomas Olivecrona

Gunilla Olivecrona

Gunilla Olivecrona

Umeå University

Publications: 97

Ira J. Goldberg

Ira J. Goldberg

New York University

Publications: 78

André Bensadoun

André Bensadoun

Cornell University

Publications: 76

Stephen G. Young

Stephen G. Young

University of California, Los Angeles

Publications: 56

Fredrik Karpe

Fredrik Karpe

University of Oxford

Publications: 53

Richard J. Deckelbaum

Richard J. Deckelbaum

Columbia University

Publications: 48

Anders Hamsten

Anders Hamsten

Karolinska Institute

Publications: 43

Loren G. Fong

Loren G. Fong

University of California, Los Angeles

Publications: 43

Sander Kersten

Sander Kersten

Wageningen University & Research

Publications: 43

Marja-Riitta Taskinen

Marja-Riitta Taskinen

University of Helsinki

Publications: 42

Michael C. Schotz

Michael C. Schotz

University of California, Los Angeles

Publications: 40

Keith N. Frayn

Keith N. Frayn

University of Oxford

Publications: 40

Olle Hernell

Olle Hernell

Umeå University

Publications: 38

Olga Stein

Olga Stein

Hebrew University of Jerusalem

Publications: 36

Michael Ploug

Michael Ploug

University of Copenhagen

Publications: 35

Antonio M. Gotto

Antonio M. Gotto

Cornell University

Publications: 35

Trending Scientists

Richard Han

Richard Han

Macquarie University

Demosthenis Teneketzis

Demosthenis Teneketzis

University of Michigan–Ann Arbor

Yu Qian

Yu Qian

South China University of Technology

Randall Guensler

Randall Guensler

Georgia Institute of Technology

Kevin S. McCann

Kevin S. McCann

University of Guelph

Richard M. Harland

Richard M. Harland

University of California, Berkeley

Katherine L. O’Brien

Katherine L. O’Brien

Johns Hopkins University

Mark Solms

Mark Solms

University of Cape Town

Thalia Wheatley

Thalia Wheatley

Dartmouth College

John H. Flavell

John H. Flavell

Stanford University

Leslie J. DeGroot

Leslie J. DeGroot

University of Chicago

Chris J. Packard

Chris J. Packard

Glasgow Royal Infirmary

Jochen Harbott

Jochen Harbott

University of Giessen

Mark K. Ferguson

Mark K. Ferguson

University of Chicago

Margaret S. Archer

Margaret S. Archer

University of Warwick

Something went wrong. Please try again later.